L L L L L L L L L L L
Chapter 1. The Role of the Nurse Practitioner as Prescriber
L L L L L L L L L
Multiple Choice
L L
Identify the choice that best completes the statement or answers the question.
L L L L L L L L L L L
L 1. Nurse practitioner prescriptive authority is regulated by:
L L L L L L L
1. The National Council of State Boards of Nursing
L L L L L L L
2. The U.S. Drug Enforcement Administration
L L L L
3. The State Board of Nursing for each state
L L L L L L L
4. The State Board of Pharmacy L L L L
L 2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber
L L L L L L L L L L L L L L
include: L
1. Nurses know more about Pharmacology than other prescribers because they take it
L L L L L L L L L L L
both in their basic nursing program and in their APRN program.
L L L L L L L L L L L
2. Nurses care for the patient from a holistic approach and include the patient in
L L L L L L L L L L L L L
decision making regarding their care.
L L L L L
3. APRNs are less likely to prescribe narcotics and other controlled substances.
L L L L L L L L L L
4. APRNs are able to prescribe independently in all states, whereas a physician’s
L L L L L L L L L L L
assistant needs to have a physician supervising their practice.
L L L L L L L L L
L 3. Clinical judgment in prescribing includes:
L L L L L
1. Factoring in the cost to the patient of the medication prescribed L L L L L L L L L L
2. Always prescribing the newest medication available for the disease process
L L L L L L L L L
3. Handing out drug samples to poor patients L L L L L L
4. Prescribing all generic medications to cut costs L L L L L L
L 4. Criteria for choosing an effective drug for a disorder include:
L L L L L L L L L L
1. Asking the patient what drug they think would work best for them
L L L L L L L L L L L
2. Consulting nationally recognized guidelines for disease management L L L L L L
3. Prescribing medications that are available as samples before writing a prescription
L L L L L L L L L L
4. Following U.S. Drug Enforcement Administration guidelines for prescribing
L L L L L L L
L 5. Nurse practitioner practice may thrive under health-care reform because of:
L L L L L L L L L L
1. The demonstrated ability of nurse practitioners to control costs and improve patient
L L L L L L L L L L L
outcomes L
2. The fact that nurse practitioners will be able to practice independently
L L L L L L L L L L
3. The fact that nurse practitioners will have full reimbursement under health-
L L L L L L L L L L
care reform L
4. The ability to shift accountability for Medicaid to the state level
L L L L L L L L L L
,Chapter 1. The Role of the Nurse Practitioner as Prescriber
L L L L L L L L L
Answer Section
L L
MULTIPLE CHOICE L
1. ANS:
L 3 PTS: 1
2. ANS:
L 2 PTS: 1
3. ANS:
L 1 PTS: 1
4. ANS:
L 2 PTS: 1
5. ANS:
L 1 PTS: 1
,Chapter 2. Review of the Basic Principles of Pharmacology
L L L L L L L L
Multiple Choice L
Identify the choice that best completes the statement or answers the question.
L L L L L L L L L L L
L 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to
L L L L L L L L L L L L L
prescribing because:
L L
1. Distribution of drugs to target tissue may be affected. L L L L L L L L
2. The solubility of the drug will not match the site of absorption.
L L L L L L L L L L L
3. There will be less free drug available to generate an effect.
L L L L L L L L L L
4. Drugs bound to albumin are readily excreted by the kidneys.
L L L L L L L L L
L 2. Drugs that have a significant first-pass effect:
L L L L L L L
1. Must be given by the enteral (oral) route only
L L L L L L L L
2. Bypass the hepatic circulation L L L
3. Are rapidly metabolized by the liver and may have little if any desired action
L L L L L L L L L L L L L
4. Are converted by the liver to more active and fat-soluble forms
L L L L L L L L L L
L L 3. The route of excretion of a volatile drug will likely be the:
L L L L L L L L L L L L
1. Kidneys
2. Lungs
3. Bile and feces L L
4. Skin
L 4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a storage
L L L L L L L L L L L
reservoir of the drug. Storage reservoirs:
L L L L L L
1. Assure that the drug will reach its intended target tissue L L L L L L L L L
2. Are the reason for giving loading doses
L L L L L L
3. Increase the length of time a drug is available and active L L L L L L L L L L
4. Are most common in collagen tissuesL L L L L
L L 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
L L L L L L L L L L L L L L L
1. Propensity to go to the target receptor L L L L L L
2. Biological half-life L
3. Pharmacodynamics
4. Safety and side effects L L L
L 6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
L L L L L L L L L L L L L L L L L L
prescription. This is considered a loading dose. A loading dose:
L L L L L L L L L L
1. Rapidly achieves drug levels in the therapeutic range L L L L L L L
2. Requires four- to five-half-lives to attain L L L L L
3. Is influenced by renal function
L L L L
4. Is directly related to the drug circulating to the target tissues
L L L L L L L L L L
L 7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect
L L L L L L L L L L L L L L L L L L
is the: L L
1. Minimum adverse effect level L L L
2. Peak of action L L
, 3. Onset of action L L
4. Therapeutic range L
L 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
L L L L L L L L L L L L L L
1. When the drug has a wide therapeutic range
L L L L L L L
2. When the drug will be administered for a short time only
L L L L L L L L L L
3. When there is a high correlation between the dose and saturation of receptor sites
L L L L L L L L L L L L L
4. To determine if a drug is in the therapeutic range
L L L L L L L L L
L L 9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration.
L L L L L L L L L L L L L L L L L
This means that the:
L L L
1. Concentration will produce therapeutic effects L L L L
2. Concentration will produce an adverse response L L L L L
3. Time between doses must be shortened
L L L L L
4. Duration of action of the drug is too long L L L L L L L L
L 10. Drugs that are receptor agonists may demonstrate what property?
L L L L L L L L L
1. Irreversible binding to the drug receptor site L L L L L L
2. Upregulation with chronic use L L L
3. Desensitization or downregulation with continuous use L L L L L
4. Inverse relationship between drug concentration and drug action
L L L L L L L
L 11. Drugs that are receptor antagonists, such as beta blockers, may cause:
L L L L L L L L L L L
1. Downregulation of the drug receptor L L L L
2. An exaggerated response if abruptly discontinued
L L L L L
3. Partial blockade of the effects of agonist drugs L L L L L L L
4. An exaggerated response to competitive drug agonists
L L L L L L
L 12. Factors that affect gastric drug absorption include:
L L L L L L L
1. Liver enzyme activity L L
2. Protein-binding properties of the drug molecule L L L L L
3. Lipid solubility of the drug L L L L
4. Ability to chew and swallow L L L L
L 13. Drugs administered via IV:
L L L L
1. Need to be lipid soluble in order to be easily absorbed
L L L L L L L L L L
2. Begin distribution into the body immediatelyL L L L L
3. Are easily absorbed if they are nonionized
L L L L L L
4. May use pinocytosis to be absorbed L L L L L
L 14. When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is:
L L L L L L L L L L L L L L L L L L L
1. The sum of the effects of each drug individually
L L L L L L L L
2. Greater than the sum of the effects of each drug individually
L L L L L L L L L L
3. Less than the effect of each drug individually
L L L L L L L
4. Not predictable, as it varies with each individual
L L L L L L L
L 15. Which of the following statements about bioavailability is true?
L L L L L L L L L
1. Bioavailability issues are especially important for drugs with narrow therapeutic L L L L L L L L L
ranges or sustained-release mechanisms.
L L L L
2. All brands of a drug have the same bioavailability.
L L L L L L L L
3. Drugs that are administered more than once a day have greater bioavailability than
L L L L L L L L L L L L